Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DGKG | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | ACAP2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | OR2G2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | MPZL3 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | TAF9B | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | SERPINB12 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | BACE2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | NXPE4 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | SGK223 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | PTPRZ1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |